RecruitingPhase 1 / Phase 2NCT06897930
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Sponsor: AstraZeneca
San Francisco, CA · Stanford, CA · +14 more sites
1 recruiting lupus studies with a site in Stanford, CA.
Sponsor: AstraZeneca
San Francisco, CA · Stanford, CA · +14 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.